▲ BUY
6
/ 10
Conviction
$ Value
$76K
Shares
10,000
Price
$8
Filed
Nov 17
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Cluster: 4 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Winton Matthew
Title
Chief Commercial and Business
CIK
0001971400
Roles
Officer
Transaction Details
Transaction Date
2025-11-14
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
10,000
Footnotes
Shares purchased in open-market transactions. | The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.53 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
Filing Info
Winton Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-18 | CRVO | ▲ | $12K |
| 2025-11-17 | CRVO | ▲ | $30K |
| 2025-11-14 | CRVO | ▲ | $76K ★ |
| 2025-10-06 | CRVO | A | $0 |
| 2025-07-01 | INZY | U | $87K |
| 2025-07-01 | INZY | D | — |
| 2025-07-01 | INZY | D | — |
| 2025-06-25 | INZY | A | $11K |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |